Alessandra Di Filippo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach	CANCER IMMUNOLOGY, IMMUNOTHERAPY	2023
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity	JOURNAL OF IMMUNOLOGY RESEARCH	2023
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients	CLINICAL CANCER RESEARCH	2022
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study	HUMAN VACCINES & IMMUNOTHERAPEUTICS	2022
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response	EBIOMEDICINE	2022
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: Systematic review and Meta-Analysis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with Immunotherapy: a novel combined profile	BIOMEDICINES	2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy	FRONTIERS IN IMMUNOLOGY	2022
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study	JOURNAL OF PERSONALIZED MEDICINE	2021
Immunogenic cell death and immunomodulatory effects of cabozantinib	FRONTIERS IN ONCOLOGY	2021
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma	CANCERS	2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients	JOURNAL OF PERSONALIZED MEDICINE	2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients	JOURNAL OF PERSONALIZED MEDICINE	2020
Immune profile of metastatic uveal melanoma during treatment with pembrolizumab	JOURNAL OF CLINICAL ONCOLOGY	2019
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells	FRONTIERS IN IMMUNOLOGY	2018